SVG-25328-09348

2 vaccinations 9 coded responses 15 check-ins 9 free-text entries 3 call cases

Sex: Female
Age at first dose: 31-35
ZIP prefix: 100 / NY
Registered: 2021-04-22

Relationship: Self
Race: White
Ethnicity: N/A

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-05
Dose 1 — Pfizer-BioNTech
2021-04-22
Registered in v-safe
2021-04-22
Survey response — day 14, dose 1
MedDRA: Fatigue, Lethargy — Feeling: Fair · Be unable to do your normal daily activities

Free text: Chronic fatigue/lethargy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-26
Dose 2 — Pfizer-BioNTech
2021-04-26
Survey response — day 0, dose 2
MedDRA: Dizziness — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-27
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-04-28
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy, Oropharyngeal pain — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities

Free text: Swollen lymph nodes/sore throat

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-29
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy, Oropharyngeal pain — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work

Free text: Swollen lymph nodes/sore throat

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-30
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-05-02
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Abdominal pain · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-05-05
Health check-in — day 7, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-05-10
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-05-17
Survey response — day 21, dose 2
MedDRA: Fatigue, Insomnia — Feeling: Fair · Be unable to do your normal daily activities

Free text: Still feeling fatigue and difficulty sleeping

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-24
Survey response — day 28, dose 2
MedDRA: Fatigue, Insomnia — Feeling: Fair · Be unable to do your normal daily activities

Free text: Fatigue and insomnia continues

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-31
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-07-28
Survey response — 3 months, dose 2
MedDRA: Exposure to allergen, Hypersensitivity — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Severe allergic reaction to unknown allergen.

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-07-28
Report sent to call center — 3 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-08-05
Call 1 — Could Not Reach Participant
2021-08-10
Call 2 — Could Not Reach Participant
2021-10-27
Survey response — 6 months, dose 2
MedDRA: Anaphylactoid reaction, Hypersensitivity — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: I've had several severe near anaphylactic allergic reactions to things I was never this allergic to.

MedDRA releases: 2024-11 · check-in free text available
2021-10-27
Report sent to call center — 6 months, dose 2
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-10-28
Call successful
Participant prefers to complete VAERS report online
2022-04-28
Survey response — 12 months, dose 2
MedDRA: Dehydroepiandrosterone decreased, Hypersensitivity, Weight increased — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Low DHEA levels and significant weight gain. Several severe allergic reactions without known trigger.

MedDRA releases: 2024-11 · check-in free text available
2022-04-28
Report sent to call center — 12 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-05-02
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-05	Pfizer-BioNTech
2	2021-04-26	Pfizer-BioNTech

Call center

3 call center cases

2 successful · 1 unsuccessful

See the call center timeline

Free text

Release 7 — day 14, dose 1

2021-04-22

Symptoms: Chronic fatigue/lethargy

Release 8 — day 0, dose 2

2021-04-26

Systemic reaction (other): Dizziness

Release 8 — days 1–6 daily, dose 2

2021-04-28

Systemic reaction (other): Swollen lymph nodes/sore throat

2021-04-29

Systemic reaction (other): Swollen lymph nodes/sore throat

Release 8 — day 21, dose 2

2021-05-17

Symptoms: Still feeling fatigue and difficulty sleeping

Release 8 — day 28, dose 2

2021-05-24

Symptoms: Fatigue and insomnia continues

Release 9 — 3 months, dose 2

2021-07-28

Symptoms: Severe allergic reaction to unknown allergen.

Release 10 — 6 months, dose 2

2021-10-27

Symptoms: I've had several severe near anaphylactic allergic reactions to things I was never this allergic to.

Release 11 — 12 months, dose 2

2022-04-28

Symptoms: Low DHEA levels and significant weight gain. Several severe allergic reactions without known trigger.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Anaphylactoid reaction	·	·	✓
SD	Dehydroepiandrosterone decreased	·	·	✓
SD	Exposure to allergen	✓	·	✓
SD	Fatigue	✓	✓	✓
SD	Hypersensitivity	✓	·	✓
SD	Insomnia	✓	✓	✓
SD	Lethargy	✓	✓	✓
SD	Weight increased	·	·	✓
SRO	Dizziness	✓	✓	✓
SRO	Lymphadenopathy	✓	✓	✓
SRO	Oropharyngeal pain	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release